Literature DB >> 26675771

Protein ingestion acutely inhibits insulin-stimulated muscle carnitine uptake in healthy young men.

Chris E Shannon1, Aline V Nixon1, Paul L Greenhaff1, Francis B Stephens2.   

Abstract

BACKGROUND: Increasing skeletal muscle carnitine content represents an appealing intervention in conditions of perturbed lipid metabolism such as obesity and type 2 diabetes but requires chronic L-carnitine feeding on a daily basis in a high-carbohydrate beverage.
OBJECTIVE: We investigated whether whey protein ingestion could reduce the carbohydrate load required to stimulate insulin-mediated muscle carnitine accretion.
DESIGN: Seven healthy men [mean ± SD age: 24 ± 5 y; body mass index (in kg/m(2)): 23 ± 3] ingested 80 g carbohydrate, 40 g carbohydrate + 40 g protein, or control (flavored water) beverages 60 min after the ingestion of 4.5 g L-carnitine tartrate (3 g L-carnitine; 0.1% (2)[H]3-L-carnitine). Serum insulin concentration, net forearm carnitine balance (NCB; arterialized-venous and venous plasma carnitine difference × brachial artery flow), and carnitine disappearance (Rd) and appearance (Ra) rates were determined at 20-min intervals for 180 min.
RESULTS: Serum insulin and plasma flow areas under the curve (AUCs) were similarly elevated by carbohydrate [4.5 ± 0.8 U/L · min (P < 0.01) and 0.5 ± 0.6 L (P < 0.05), respectively] and carbohydrate+protein [3.8 ± 0.6 U/L · min (P < 0.01) and 0.4 ± 0.6 L (P = 0.05), respectively] consumption, respectively, compared with the control visit (0.04 ± 0.1 U/L · min and -0.5 ± 0.2 L). Plasma carnitine AUC was greater after carbohydrate+protein consumption (3.5 ± 0.5 mmol/L · min) than after control and carbohydrate visits [2.1 ± 0.2 mmol/L · min (P < 0.05) and 1.9 ± 0.3 mmol/L · min (P < 0.01), respectively]. NCB AUC with carbohydrate (4.1 ± 3.1 μmol) was greater than during control and carbohydrate-protein visits (-8.6 ± 3.0 and -14.6 ± 6.4 μmol, respectively; P < 0.05), as was Rd AUC after carbohydrate (35.7 ± 25.2 μmol) compared with control and carbohydrate consumption [19.7 ± 15.5 μmol (P = 0.07) and 14.8 ± 9.6 μmol (P < 0.05), respectively].
CONCLUSIONS: The insulin-mediated increase in forearm carnitine balance with carbohydrate consumption was acutely blunted by a carbohydrate+protein beverage, which suggests that carbohydrate+protein could inhibit chronic muscle carnitine accumulation.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  doubly labeled water; energy requirement; resting energy expenditure; short bowel syndrome; total energy expenditure

Mesh:

Substances:

Year:  2015        PMID: 26675771      PMCID: PMC4756606          DOI: 10.3945/ajcn.115.119826

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  48 in total

1.  Effect of two methods of hand heating on body temperature, forearm blood flow, and deep venous oxygen saturation.

Authors:  I W Gallen; I A Macdonald
Journal:  Am J Physiol       Date:  1990-11

2.  THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES.

Authors:  K L Zierler
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

3.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

4.  Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance.

Authors:  Sandra Wächter; Michael Vogt; Roland Kreis; Chris Boesch; Peter Bigler; Hans Hoppeler; Stephan Krähenbühl
Journal:  Clin Chim Acta       Date:  2002-04       Impact factor: 3.786

5.  Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans.

Authors:  Benjamin T Wall; Francis B Stephens; Dumitru Constantin-Teodosiu; Kanagaraj Marimuthu; Ian A Macdonald; Paul L Greenhaff
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

6.  Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites.

Authors:  C J Rebouche; C A Chenard
Journal:  J Nutr       Date:  1991-04       Impact factor: 4.798

7.  Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise.

Authors:  M D Vukovich; D L Costill; W J Fink
Journal:  Med Sci Sports Exerc       Date:  1994-09       Impact factor: 5.411

8.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

Review 9.  Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.

Authors:  E P Brass
Journal:  Clin Ther       Date:  1995 Mar-Apr       Impact factor: 3.393

10.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

View more
  2 in total

Review 1.  "Nutraceuticals" in relation to human skeletal muscle and exercise.

Authors:  Colleen S Deane; Daniel J Wilkinson; Bethan E Phillips; Kenneth Smith; Timothy Etheridge; Philip J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-31       Impact factor: 4.310

2.  Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise.

Authors:  Carolyn Chee; Chris E Shannon; Aisling Burns; Anna L Selby; Daniel Wilkinson; Kenneth Smith; Paul L Greenhaff; Francis B Stephens
Journal:  Aging Cell       Date:  2021-01-19       Impact factor: 9.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.